How Licensing Agreements Allow IP Owners to Monetize Their Work

Royalties Generated $346 Billion Globally in 2022

Global royalty and licensing payments exceeded $346 billion in 2022, according to the World Intellectual Property Organization. This figure — larger than the GDP of most countries — represents the economic value of licensing as a mechanism for separating the ownership of intellectual assets from their commercial exploitation. Companies like Qualcomm, ARM Holdings, and Nokia generate billions annually not by building every device that uses their patents, but by licensing the patents to manufacturers who do the building. The music industry depends almost entirely on licensing — artists write songs once, then license them repeatedly to streaming platforms, film studios, advertisers, and broadcasters.

A license is fundamentally a permission: the IP owner (licensor) grants another party (licensee) specified rights to use the IP under defined conditions, retaining ownership. The licensor can grant multiple licenses to multiple parties, license different rights to different parties, and retain enforcement rights against infringers who use the IP without permission. This flexibility makes licensing one of the most versatile monetization tools in intellectual property law.

The Core License Categories

Every licensing agreement must address several structural questions that define the scope of rights being granted. How these questions are answered determines the commercial value of the license and the legal protections each party receives.

• Exclusive license: The licensor grants rights only to one licensee within the defined scope — the licensor itself may be prohibited from competing, depending on the agreement; highest value, commands highest royalty
• Non-exclusive license: The licensor retains the right to grant the same license to multiple parties; lower exclusivity premium but allows parallel revenue from multiple licensees
• Sole license: Only one licensee, but the licensor retains its own right to use the IP (a middle ground between exclusive and non-exclusive)
• Sublicensable vs. non-sublicensable: Whether the licensee can grant further licenses to third parties — important for distribution arrangements and software platforms
• Field-of-use restriction: Licensing the same patent for pharmaceutical use to one party and agricultural use to another, extracting maximum value from each market separately

Royalty Structures: How Payments Are Calculated

Royalty structures vary by IP type and industry, but several standard approaches appear across most licensing categories.

Field-of-Use Restrictions and Geographic Limitations

Field-of-use restrictions allow IP owners to partition their rights geographically and by application domain, maximizing revenue extraction across different markets. Pharmaceutical companies commonly grant a license to use a drug compound for one therapeutic indication while licensing the same compound to a different company for a different indication. Each license can command separate royalty rates appropriate to the market value of each application.

Geographic limitations are standard in entertainment licensing: a film studio may license theatrical rights in one country to one distributor, streaming rights to another, and DVD rights to a third. Each licensor-licensee relationship is independently negotiated and structured. Parallel importing rules — particularly in the European Union, where exhaustion of rights after first authorized sale within the EU limits geographic restrictions — affect how these limitations can be enforced internationally.

• U.S. patent exhaustion doctrine (established in Impression Products v. Lexmark International, 2017) limits post-sale restrictions even in domestic licenses
• Geographic restrictions in copyright licenses must comply with EU exhaustion rules for digital goods after the Court of Justice's ruling in UsedSoft v. Oracle (2012)
• Trademark licenses require quality control provisions — a licensor who grants trademark rights without maintaining quality control may face naked license arguments that could invalidate the trademark

Audit Rights: The Overlooked Provision

Running royalty licenses create an inherent information asymmetry: the licensor depends on the licensee's self-reporting of sales, but the licensor cannot directly verify those reports. Audit rights address this by giving the licensor the contractual right to inspect the licensee's books and records to verify royalty calculations.

Surveys of intellectual property practitioners consistently find that royalty audits produce underpayment findings in approximately 60–70% of cases, with average underpayments of 15–25% of total royalties owed. The reasons are varied: definitional disagreements about what constitutes net sales, failure to account for sales through affiliate channels, and in some cases deliberate underreporting.

Effective audit provisions specify: who may conduct the audit (independent certified public accountant), frequency (typically once per year or once per two years), notice period required before audit, cost allocation (licensee pays audit costs if underpayment exceeds a threshold, typically 5%), and the statute of limitations for retroactive claims (typically 3–5 years).

Technology Transfer Agreements and University Licensing

Universities and research institutions license patents arising from federally funded research under the framework established by the Bayh-Dole Act of 1980, which gave universities ownership rights to federally funded inventions. The University of California system, Stanford, MIT, and other research universities generate tens of millions annually in technology transfer licensing fees. Stanford's cumulative licensing income from Google's PageRank patent alone exceeded $336 million before the patent expired in 2011.

This article is for informational purposes only and does not constitute legal advice.